Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,729–1,736 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Finch Therapeutics Group Inc. CP101 - (PRISM-EXT) C. difficile Infection Phase 2 Trial Discontinued Oral Antibiotic
Finch Therapeutics Group Inc. CP101 - (PRISM3) Clostridioides difficile infection Phase 2 Oral Gastroenterology
Forte Biosciences Inc. FB102 Celiac Disease Phase 2 Ongoing Intravenous Gastroenterology
Forte Biosciences Inc. FB-401 Atopic Dermatitis Phase 2 Trial Discontinued Topical Immunology
Fortress Biotech Inc. CEVA101 Severe Traumatic Brain Injury Phase 2 Trial Discontinued intravenous Neurology
Fortress Biotech Inc. CMV-MVA Triplex Vaccination Hematopoietic stem cell transplantation (HSCT) Phase 2 Enrollment Initiation Intramuscular Hematology
Fortress Biotech Inc. Dotinurad - (TOPAZ) Tophaceous gout Phase 3 Ongoing Oral N/A
Fortress Biotech Inc. MB-107 X-linked Severe Combined Immunodeficiency (XSCID) - newly diagnosed infants Phase 2 Data Released Intravenous Genetic Disorder